Freenome Company
Freenome is a biotech company developing accurate, accessible, and non-invasive disease screening products for proactively treating cancer and other diseases at their most manageable stages. The company is developing a simple blood test to detect early-stage cancer and make treatments more effective and provides a platform that helps design healthy conditions for an individual based on his/her cell-free genome. The company aims to reinvent disease management through systematized early detection and intervention. Charles Roberts, Gabriel Otte, Riley Ennis, and Michael Otte launched the company in 2014 in South San Francisco, California.
Investors
.png)
.jpeg)
.png)
.jpg)
.png)
(Reupload).png)
.png)
.png)
.png)
(Reupload).png)
.png)
.png)
(Reupload).png)
(Reupload).png)
Technology:
Сancer Diagnostics
Industry:
Data processing
Headquarters:
South San Francisco, California, United States
Founded Date:
2014-01-01
Employees Number:
251-500
Funding Status:
Late Stage Venture
Investors Number:
50
Total Funding:
1097550000
Estimated Revenue:
$100M to $500M
Last Funding Date:
2022-01-11
Last Funding Type:
Corporate Round
Register and Claim Ownership